The author reported an increase in blood glucose, insulin, HOMA-IR, and changes in the lipid profile compatible with dyslipidemia after induction using an HFD with 60% fat for 91 days and the administration of 45 mg/kg of STZ i.p. in a single dose. The gene discussed is INS; the disease is metabolic syndrome.